Drug company gives ofatumumab update
Drug company gives ofatumumab update
Biotech firm Genmab has announced an update on development plans for ofatumumab in autoimmune indications focusing on relapsing multiple sclerosis following the transfer of the rights to ofatumumab from GlaxoSmithKline (GSK) to Novartis at the end of 2015...Read more - http://www.ms-uk.org/MSnews
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 1381 Views
-
Last post by frodo
-
- 0 Replies
- 1026 Views
-
Last post by frodo
-
- 0 Replies
- 2623 Views
-
Last post by NHE
-
- 0 Replies
- 1322 Views
-
Last post by frodo
-
- 0 Replies
- 1305 Views
-
Last post by frodo
-
- 0 Replies
- 1281 Views
-
Last post by frodo
-
- 0 Replies
- 1670 Views
-
Last post by NHE
-
- 0 Replies
- 523 Views
-
Last post by NHE
-
- 1 Replies
- 3164 Views
-
Last post by Tif